I-Mab Highlights Pipeline Success and Strong Finances
PremiumCompany AnnouncementsI-Mab Highlights Pipeline Success and Strong Finances
23d ago
I-Mab Reports 1H 2024 Financial Results, Pipeline Progress, and Business Updates
Premium
Press Releases
I-Mab Reports 1H 2024 Financial Results, Pipeline Progress, and Business Updates
23d ago
I-Mab Announces New Auditor for Strategic Growth
Premium
Company Announcements
I-Mab Announces New Auditor for Strategic Growth
1M ago
I-Mab and Bristol Myers Squibb Tackle Gastric Cancer
PremiumCompany AnnouncementsI-Mab and Bristol Myers Squibb Tackle Gastric Cancer
4M ago
I-Mab announces clinical trial collaboration with Bristol Myers
Premium
The Fly
I-Mab announces clinical trial collaboration with Bristol Myers
4M ago
I-Mab’s Ragistomig Shows Promise in Phase 1 Trials
Premium
Company Announcements
I-Mab’s Ragistomig Shows Promise in Phase 1 Trials
4M ago
I-Mab Announces Major Leadership Reshuffle
PremiumCompany AnnouncementsI-Mab Announces Major Leadership Reshuffle
6M ago
I-Mab price target lowered to $10 from $15 at Piper Sandler
Premium
The Fly
I-Mab price target lowered to $10 from $15 at Piper Sandler
6M ago
I-Mab price target lowered to $8 from $18 at H.C. Wainwright
Premium
The Fly
I-Mab price target lowered to $8 from $18 at H.C. Wainwright
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100